13F HOLDINGS REPORT
MPM ASSET MANAGEMENT LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000950123-24-008624
Total Value
$182.1M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Entrada Therapeutics, Inc. | TRDA | 4,425,784 | $63.1M | 34.64% |
| 2 | Dyne Therapeutics, Inc. | DYN | 1,561,496 | $55.1M | 30.26% |
| 3 | iTeos Therapeutics, Inc. | 46565G104 | 2,738,785 | $40.6M | 22.32% |
| 4 | Werewolf Therapeutics, Inc. | HOWL | 4,284,172 | $10.5M | 5.74% |
| 5 | Repare Therapeutics, Inc. | 760273102 | 2,242,636 | $7.4M | 4.06% |
| 6 | Adaptimmune Therapeutics plc | ADTI | 5,555,461 | $5.4M | 2.97% |